167 related articles for article (PubMed ID: 7238955)
1. Augmentation of antitumour activity of xenogeneic antiserum by normal xenogeneic spleen cells in mice.
Dobaczewska H; Lasek W; Marczak M; Obłakowski P; Jakóbisiak M
Folia Biol (Krakow); 1981; 29(1):77-81. PubMed ID: 7238955
[No Abstract] [Full Text] [Related]
2. Augmentation of in vivo antitumour activity of xenogeneic antiserum by autotransplanted normal spleen cells in mice.
Jakóbisiak M; Kańtoch M; Lasek W; Rozmysłowicz T; Obłakowski P; Dobaczewska H
Eur J Cancer (1965); 1981 Jan; 17(1):77-80. PubMed ID: 7262149
[No Abstract] [Full Text] [Related]
3. Natural cell-mediated cytotoxicity in Ehrlich ascites tumor-bearing mice.
Olinescu A; Hristescu S; Mazilu E
Neoplasma; 1983; 30(2):147-52. PubMed ID: 6843720
[TBL] [Abstract][Full Text] [Related]
4. A search for lymphocyte-derived macrophages during xenogeneic graft-verus-host reactions induced by rat thoracic duct cells.
Bell EB; Shand FL
Immunology; 1972 Apr; 22(4):537-47. PubMed ID: 4401408
[TBL] [Abstract][Full Text] [Related]
5. Production of tumor-specific antibody in the xenogeneic host: use of blocking antibody.
Weiner RS; Hubbard JD; Mardiney MR
J Natl Cancer Inst; 1972 Oct; 49(4):1063-70. PubMed ID: 4117316
[No Abstract] [Full Text] [Related]
6. Transfer by serum and cells of resistance to infection with Strongyloides ratti in mice.
Dawkins HJ; Grove DI
Immunology; 1981 Jun; 43(2):317-22. PubMed ID: 7251056
[TBL] [Abstract][Full Text] [Related]
7. Surface antigen on Ehrlich ascites tumor cells.
Pessina A; Brambilla P; Mocarelli P
Biomedicine; 1980; 33(4):105-9. PubMed ID: 7000194
[TBL] [Abstract][Full Text] [Related]
8. [Release of suppressor factors by the lymphocytes of mice in contact with syngeneic and xenogeneic erythrocytes].
Leskov VP; Cheredeev AN; Solov'ev VV
Biull Eksp Biol Med; 1977 Mar; 83(3):308-10. PubMed ID: 322764
[TBL] [Abstract][Full Text] [Related]
9. Islet xenografts in mice and rats: II. Mixed islet-spleen cell assay to analyze nitric oxide production and inhibition in xenogeneic species combinations.
Jahr H; Nicolae M; Braun K; Ketchum R; Koeberlein B; Barker CF; Brayman KL
Transplant Proc; 1994 Apr; 26(2):775. PubMed ID: 8171658
[No Abstract] [Full Text] [Related]
10. Suppression of cell-mediated immunity through immune spleen cells against Ehrlich ascites tumor.
Okubo S
Nagoya J Med Sci; 1971 Mar; 33(4):329-40. PubMed ID: 5554418
[No Abstract] [Full Text] [Related]
11. Effect of cyclophosphamide on tumor cell sensitivity to the action of immunological effectors.
Culo F; Marić M; Morović-Vergles J
In Vivo; 1995; 9(5):439-46. PubMed ID: 8900921
[TBL] [Abstract][Full Text] [Related]
12. Modulation of natural killer cell activity, antibody-dependent cellular cytotoxicity, and antibody-dependent complement-mediated cytotoxicity by andrographolide in normal and Ehrlich ascites carcinoma-bearing mice.
Sheeja K; Kuttan G
Integr Cancer Ther; 2007 Mar; 6(1):66-73. PubMed ID: 17351028
[TBL] [Abstract][Full Text] [Related]
13. Resistance and susceptibility to tumours. IV. The temporary survival and rejection of the Ehrlich ascites carcinoma in xenogeneic hosts.
Dvorák R; Karásek J
Neoplasma; 1970; 17(4):361-71. PubMed ID: 4394171
[No Abstract] [Full Text] [Related]
14. Survival and tissue localization of xenogeneic human lymphocytes in hypothymic nude mice: observations in normal subjects and multiple sclerosis.
Bernard CC; Mackay IR
Clin Exp Immunol; 1984 Jan; 55(1):211-6. PubMed ID: 6692596
[TBL] [Abstract][Full Text] [Related]
15. Time-lapse changes in the concomitant immunity of lymphoid cells from different regions of Ehrlich tumor-bearing mice and alterations in blastformation rate by PHA-stimulation.
Orita K; Tomoyasu S; Kaneda S; Miwa H; Konaga E
Acta Med Okayama (1952); 1972 Aug; 26(3):81-8. PubMed ID: 4268711
[No Abstract] [Full Text] [Related]
16. Resistance and susceptibility to tumours. 3. Effect of some derivatives from immunized animals on the Bo4 and Ehrlich carcinomas.
Dvorák R; Chlumecký J
Neoplasma; 1969; 16(6):613-24. PubMed ID: 5369028
[No Abstract] [Full Text] [Related]
17. Antitumor resistance activation in mice: can the immunological memory cells enhance resistance?
Kazmin SD; Todor IN; Chekhun VF
J Exp Clin Cancer Res; 2005 Dec; 24(4):585-93. PubMed ID: 16471321
[TBL] [Abstract][Full Text] [Related]
18. Specific antibody production to a recall or a neoantigen by SCID mice reconstituted with human peripheral blood lymphocytes.
Nonoyama S; Smith FO; Ochs HD
J Immunol; 1993 Oct; 151(7):3894-901. PubMed ID: 8376809
[TBL] [Abstract][Full Text] [Related]
19. Changes in the electrophoretic mobility of mouse lymphocytes, thymocytes, macrophages and tumour cells following immunisation.
Hartveit F; Cater DB; Mehrishi JN
Br J Exp Pathol; 1968 Dec; 49(6):634-47. PubMed ID: 5706992
[No Abstract] [Full Text] [Related]
20. Angiogenesis induction by xenogeneic lymphoid and non-lymphoid cells in mice.
Kamiński MJ; Bem W; Majewski S; Kamińska G; Szmurło A
Arch Immunol Ther Exp (Warsz); 1981; 29(4):521-3. PubMed ID: 6174103
[No Abstract] [Full Text] [Related]
[Next] [New Search]
